Patients with venous thromboembolism (VTE) initiating oral anticoagulants have an increased risk for bleeding when using nonsteroidal anti-inflammatory drugs (NSAIDs), according to a study published ...
Warfarin, the first VKA anticoagulant, was approved more than 70 years ago yet no significant ... and kidney impairment effects, which are common in these patients. Tecarfarin has an orphan drug ...